WO1997045009A2 - Long-term shelf preservation by vitrification - Google Patents
Long-term shelf preservation by vitrification Download PDFInfo
- Publication number
- WO1997045009A2 WO1997045009A2 PCT/US1997/008974 US9708974W WO9745009A2 WO 1997045009 A2 WO1997045009 A2 WO 1997045009A2 US 9708974 W US9708974 W US 9708974W WO 9745009 A2 WO9745009 A2 WO 9745009A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- temperature
- storage
- sample
- biologically active
- dehydration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/16—Physical preservation processes
- A01N1/162—Temperature processes, e.g. following predefined temperature changes over time
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Definitions
- the dehydration temperature should be higher than the suggested storage temperature and the glass state should be subsequently achieved by cooling after dehydration.
- implementing this directive in some cases requires only drying at room temperatures followed by cooling to a lower-than-room-temperature storage temperature; in other instances the present method requires careful heating of the substance to be vitrified to a temperature above room temperature, followed by dehydration and subsequent cooling to room temperature.
- the invention described herein overcomes the deficiencies of the prior art and allows preservation and storage of specimens in the actual glass state without loss of biological activity during storage.
- Biological specimens which can be vitrified to a glass state include, without limitation, proteins, enzymes, serums, vaccines, viruses, liposomes, cells and in certain instances certain multicellular specimens.
- the shelf storage time in the glass state is practically unlimited and there is no need to perform accelerated aging to estimate the safe storage time.
- the key to genuine vitrification is to conduct the dehydration at a temperature higher than the suggested storage temperature (T s ) to achieve the glass transition temperature (T_, T g > T s ) followed by cooling of the sample to the suggested storage temperature, T s .
- vitrification refers to the transformation of a liquid into an amorphous solid. While liquid-to-glass transition may not yet be completely understood, it is well established that liquid-to-glass transition is characterized by a simultaneous decrease in entropy, sharp decreases in heat capacity and expansion coefficient, and large increases in viscosity.
- Several microscopic models have been proposed to explain liquid-to- glass transition, including free volume theory, percolation theory, mode coupling theories and others.
- Theories are unimportant, however, as long as the practice of the invention reliable experimental methods for establishing T g are used. The recommended method is the temperature stimulated depolarization current method known in the art.
- the samples should be dehydrated so that T g actually becomes higher than T s .
- different dehydration methods may be applied. For example, freezing may allow storage at a temperature less than T ⁇ , which is the vitrification temperature of the maximum freeze dehydrated sample (or solution) .
- Appropriate dehydration according to the invention may allow storage at ambient temperatures.
- the only way to achieve T g > T s at constant hydrostatic pressure is to dehydrate the samples at a temperature that is higher than the glass transition temperature. This has to be done despite risk of heat degradation of the specimen.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dentistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Developmental Biology & Embryology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Sampling And Sample Adjustment (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97927769A EP1015826A2 (en) | 1996-05-29 | 1997-05-28 | Long-term shelf preservation by vitrification |
| JP09542857A JP2000511059A (en) | 1996-05-29 | 1997-05-28 | Long-term storage by vitrification |
| AU32145/97A AU3214597A (en) | 1996-05-29 | 1997-05-28 | Long-term shelf preservation by vitrification |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1857396P | 1996-05-29 | 1996-05-29 | |
| US60/018,573 | 1996-05-29 | ||
| US78547297A | 1997-01-17 | 1997-01-17 | |
| US08/785,472 | 1997-01-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1997045009A2 true WO1997045009A2 (en) | 1997-12-04 |
| WO1997045009A3 WO1997045009A3 (en) | 1997-12-31 |
Family
ID=26691265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1997/008974 Ceased WO1997045009A2 (en) | 1996-05-29 | 1997-05-28 | Long-term shelf preservation by vitrification |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20010012610A1 (en) |
| EP (1) | EP1015826A2 (en) |
| JP (1) | JP2000511059A (en) |
| AU (1) | AU3214597A (en) |
| CA (1) | CA2256333A1 (en) |
| WO (1) | WO1997045009A2 (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999027071A1 (en) * | 1997-11-26 | 1999-06-03 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
| WO2000015032A1 (en) * | 1998-09-11 | 2000-03-23 | The General Hospital Corporation Doing Business As Massachusetts General Hospital | Controlled reversible poration for preservation of biological materials |
| JP2002534079A (en) * | 1999-01-05 | 2002-10-15 | ユニバーサル プリザーベーション テクノロジーズ インコーポレイテッド | Preservation of sensitive biological materials at ambient temperature by vitrification |
| US6511699B1 (en) | 1999-03-31 | 2003-01-28 | Cornell Research Foundation, Inc. | Enzymes with improved phytase activity |
| WO2005117962A1 (en) | 2004-06-02 | 2005-12-15 | Victor Bronshtein | Preservation by vaporization |
| US7026150B2 (en) | 1998-06-25 | 2006-04-11 | Cornell Research Foundation, Inc. | Overexpression of phytase genes in yeast systems |
| US7300781B2 (en) | 1999-11-18 | 2007-11-27 | Cornell Research Foundation, Inc. | Site-directed mutagenesis of Escherichia coli phytase |
| US7309505B2 (en) | 2002-09-13 | 2007-12-18 | Cornell Research Foundation, Inc. | Using mutations to improve Aspergillus phytases |
| AU2003287980B2 (en) * | 2002-11-01 | 2009-06-25 | Glaxosmithkline Biologicals S.A. | Drying process |
| US7833743B2 (en) | 2001-10-31 | 2010-11-16 | Phytex, Llc | Phytase-containing animal food and method |
| US7919297B2 (en) | 2006-02-21 | 2011-04-05 | Cornell Research Foundation, Inc. | Mutants of Aspergillus niger PhyA phytase and Aspergillus fumigatus phytase |
| US8540984B2 (en) | 2006-08-03 | 2013-09-24 | Cornell Research Foundation, Inc. | Phytases with improved thermal stability |
| EP3474665A4 (en) * | 2016-06-24 | 2020-01-01 | Osiris Therapeutics, Inc. | VIABLE LYOPHILIZED COMPOSITIONS OBTAINED FROM HUMAN TISSUES, AND METHODS OF MAKING SAME |
| US11318168B2 (en) | 2016-06-24 | 2022-05-03 | Osiris Therapeutics, Inc. | Human tissue derived compositions and uses thereof |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7811558B2 (en) * | 2004-08-12 | 2010-10-12 | Cellphire, Inc. | Use of stabilized platelets as hemostatic agent |
| CN101072506B (en) | 2004-08-12 | 2010-05-12 | 塞尔菲乐有限公司 | Methods of making freeze-dried platelets, compositions comprising freeze-dried platelets and methods of use |
| US20060051731A1 (en) * | 2004-08-12 | 2006-03-09 | David Ho | Processes for preparing lyophilized platelets |
| US20060035383A1 (en) * | 2004-08-12 | 2006-02-16 | David Ho | Dry platelet preparations for use in diagnostics |
| WO2007079147A2 (en) | 2005-12-28 | 2007-07-12 | Advanced Bionutrition Corporation | A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| US8097403B2 (en) * | 2006-12-14 | 2012-01-17 | Cellphire, Inc. | Freeze-dried platelets, method of making and method of use as a diagnostic agent |
| EP2117354B1 (en) | 2006-12-18 | 2018-08-08 | Advanced BioNutrition Corp. | A dry food product containing live probiotic |
| CA2694083A1 (en) | 2007-07-26 | 2009-01-29 | Sanofi Pasteur Limited | Antigen-adjuvant compositions and methods |
| WO2010111565A2 (en) | 2009-03-27 | 2010-09-30 | Advanced Bionutrition Corporation | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| EP2435554B1 (en) | 2009-05-26 | 2017-07-26 | Advanced Bionutrition Corporation | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
| US20110183311A1 (en) * | 2010-01-27 | 2011-07-28 | David Ho | Dry platelet preparations for use in diagnostics |
| US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
| PL2529004T3 (en) | 2010-01-28 | 2017-12-29 | Advanced Bionutrition Corporation | Dry glassy composition comprising a bioactive material |
| ES2394614T3 (en) | 2010-03-29 | 2013-02-04 | Siemens Aktiengesellschaft | Coupling an adjustment drive with a valve by using a clamping element that fits into a recess |
| US9388452B2 (en) * | 2010-04-08 | 2016-07-12 | Baxalta Incorporated | Methods for modeling protein stability |
| AR082682A1 (en) | 2010-08-13 | 2012-12-26 | Advanced Bionutrition Corp | STABILIZING DRY STORAGE COMPOSITION FOR BIOLOGICAL MATERIALS |
| MX350096B (en) * | 2011-08-12 | 2017-08-25 | Merial Inc | Vacuum -assisted preservation of biological products, in particular of vaccines. |
| MY194231A (en) | 2015-07-29 | 2022-11-23 | Advanced Bionutrition Corp | Stable dry probiotic compositions for special dietary uses |
| US12558395B2 (en) | 2015-07-29 | 2026-02-24 | Advanced Bionutrition Corp. | Stable dry probiotic compositions for special dietary uses |
| CA3121200A1 (en) | 2018-11-30 | 2020-06-04 | Cellphire, Inc. | Platelets as delivery agents |
| WO2020112963A1 (en) | 2018-11-30 | 2020-06-04 | Cellphire, Inc. | Platelets as delivery agents |
| IL322149A (en) | 2019-05-03 | 2025-09-01 | Cellphire Inc | Materials and methods for producing blood products |
| CN114450066A (en) | 2019-08-16 | 2022-05-06 | 塞尔菲乐有限公司 | Thrombosomes as antiplatelet agent reversal agents |
| CA3170196A1 (en) | 2020-02-04 | 2021-08-12 | Cellphire, Inc. | Anti-fibrinolytic loaded platelets |
| TW202245814A (en) | 2021-02-17 | 2022-12-01 | 美商賽菲爾公司 | Freeze-dried platelet derivative compositions for treating antiplatelet-induced coagulopathy |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5098893A (en) | 1989-02-16 | 1992-03-24 | Pafra Limited | Storage of materials |
| US5290765A (en) | 1990-09-14 | 1994-03-01 | Boyce Thompson Institute For Plant Research, Inc. | Method of protecting biological materials from destructive reactions in the dry state |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4865871A (en) * | 1983-08-23 | 1989-09-12 | Board Of Regents The University Of Texas System | Method for cryopreparing biological tissue |
| US5087461A (en) * | 1989-10-02 | 1992-02-11 | Nabisco Brands, Inc. | Double-encapsulated compositions containing volatile and/or labile components, and processes for preparation and use thereof |
| CA2051092C (en) * | 1990-09-12 | 2002-07-23 | Stephen A. Livesey | Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions |
| AU659645B2 (en) * | 1991-06-26 | 1995-05-25 | Inhale Therapeutic Systems | Storage of materials |
| US6277828B1 (en) * | 1993-08-20 | 2001-08-21 | Syntex (U.S.A.) Inc. | Pharmaceutical formulations of nerve growth factor |
| US5565318A (en) * | 1994-09-02 | 1996-10-15 | Pharmacia Biotech, Inc. | Room temperature stable reagent semi-spheres |
| FR2728436A1 (en) * | 1994-12-26 | 1996-06-28 | Roquette Freres | Sugar-free boiled sweets contg. polyol and with high water content |
| US5762961A (en) * | 1996-02-09 | 1998-06-09 | Quadrant Holdings Cambridge Ltd. | Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof |
-
1997
- 1997-05-28 EP EP97927769A patent/EP1015826A2/en not_active Withdrawn
- 1997-05-28 CA CA002256333A patent/CA2256333A1/en not_active Abandoned
- 1997-05-28 AU AU32145/97A patent/AU3214597A/en not_active Abandoned
- 1997-05-28 WO PCT/US1997/008974 patent/WO1997045009A2/en not_active Ceased
- 1997-05-28 JP JP09542857A patent/JP2000511059A/en not_active Ceased
-
2000
- 2000-12-12 US US09/734,970 patent/US20010012610A1/en not_active Abandoned
-
2002
- 2002-06-18 US US10/174,007 patent/US20030022333A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5098893A (en) | 1989-02-16 | 1992-03-24 | Pafra Limited | Storage of materials |
| US5290765A (en) | 1990-09-14 | 1994-03-01 | Boyce Thompson Institute For Plant Research, Inc. | Method of protecting biological materials from destructive reactions in the dry state |
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999027071A1 (en) * | 1997-11-26 | 1999-06-03 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
| US8993300B2 (en) | 1998-06-25 | 2015-03-31 | Cornell Research Foundation, Inc. | Overexpression of phytase genes in yeast systems |
| US7026150B2 (en) | 1998-06-25 | 2006-04-11 | Cornell Research Foundation, Inc. | Overexpression of phytase genes in yeast systems |
| WO2000015032A1 (en) * | 1998-09-11 | 2000-03-23 | The General Hospital Corporation Doing Business As Massachusetts General Hospital | Controlled reversible poration for preservation of biological materials |
| US6127177A (en) * | 1998-09-11 | 2000-10-03 | Massachusetts Institute Of Technology | Controlled reversible poration for preservation of biological materials |
| US6902931B1 (en) | 1998-09-11 | 2005-06-07 | The General Hospital Coporation | Controlled reversible poration for preservation of biological materials |
| JP2002534079A (en) * | 1999-01-05 | 2002-10-15 | ユニバーサル プリザーベーション テクノロジーズ インコーポレイテッド | Preservation of sensitive biological materials at ambient temperature by vitrification |
| US6511699B1 (en) | 1999-03-31 | 2003-01-28 | Cornell Research Foundation, Inc. | Enzymes with improved phytase activity |
| US6974690B2 (en) | 1999-03-31 | 2005-12-13 | Cornell Research Foundation, Inc. | Phosphatases with improved phytase activity |
| US7300781B2 (en) | 1999-11-18 | 2007-11-27 | Cornell Research Foundation, Inc. | Site-directed mutagenesis of Escherichia coli phytase |
| US7833743B2 (en) | 2001-10-31 | 2010-11-16 | Phytex, Llc | Phytase-containing animal food and method |
| US7309505B2 (en) | 2002-09-13 | 2007-12-18 | Cornell Research Foundation, Inc. | Using mutations to improve Aspergillus phytases |
| US7736680B2 (en) | 2002-09-13 | 2010-06-15 | Cornell Research Foundation, Inc. | Using mutations to improve Aspergillus phytases |
| AU2003287980B2 (en) * | 2002-11-01 | 2009-06-25 | Glaxosmithkline Biologicals S.A. | Drying process |
| EP1750760A4 (en) * | 2004-06-02 | 2012-08-29 | Victor Bronshtein | PRESERVATION BY EVAPORATION |
| WO2005117962A1 (en) | 2004-06-02 | 2005-12-15 | Victor Bronshtein | Preservation by vaporization |
| US9469835B2 (en) | 2004-06-02 | 2016-10-18 | Victor Bronshtein | Preservation by vaporization |
| US7919297B2 (en) | 2006-02-21 | 2011-04-05 | Cornell Research Foundation, Inc. | Mutants of Aspergillus niger PhyA phytase and Aspergillus fumigatus phytase |
| US8540984B2 (en) | 2006-08-03 | 2013-09-24 | Cornell Research Foundation, Inc. | Phytases with improved thermal stability |
| EP3474665A4 (en) * | 2016-06-24 | 2020-01-01 | Osiris Therapeutics, Inc. | VIABLE LYOPHILIZED COMPOSITIONS OBTAINED FROM HUMAN TISSUES, AND METHODS OF MAKING SAME |
| US11318168B2 (en) | 2016-06-24 | 2022-05-03 | Osiris Therapeutics, Inc. | Human tissue derived compositions and uses thereof |
| US12310993B2 (en) | 2016-06-24 | 2025-05-27 | Osiris Therapeutics, Inc. | Human tissue derived compositions and uses thereof |
| EP4595748A1 (en) * | 2016-06-24 | 2025-08-06 | Osiris Therapeutics, Inc. | Viable lyophilized compositions derived from human tissues and methods of making the same |
Also Published As
| Publication number | Publication date |
|---|---|
| AU3214597A (en) | 1998-01-05 |
| US20030022333A1 (en) | 2003-01-30 |
| US20010012610A1 (en) | 2001-08-09 |
| JP2000511059A (en) | 2000-08-29 |
| EP1015826A2 (en) | 2000-07-05 |
| WO1997045009A3 (en) | 1997-12-31 |
| CA2256333A1 (en) | 1997-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20010012610A1 (en) | Long-term shelf preservation by vitrification | |
| US6127177A (en) | Controlled reversible poration for preservation of biological materials | |
| US6653062B1 (en) | Preservation and storage medium for biological materials | |
| US6509146B1 (en) | Scalable long-term shelf preservation of sensitive biological solutions and suspensions | |
| Sun et al. | Cytoplasmic vitrification and survival of anhydrobiotic organisms | |
| EA001138B1 (en) | Preservation by foam formation | |
| KR101410065B1 (en) | Method for preserving valuable intracellular materials stably at room temperature | |
| Sun | Glassy state and seed storage stability: the WLF kinetics of seed viability loss at T> T g and the plasticization effect of water on storage stability | |
| EP1032647B1 (en) | Preservation of sensitive biological samples by vitrification | |
| CN115024310B (en) | A cell freeze-dried preservative and preparation method thereof | |
| Franks | Biological freezing and cryofixation | |
| EA004131B1 (en) | Method for preservation of viruses and micoplasma | |
| US5849473A (en) | Method of lyophilization of mammalian sperm cells | |
| US20030091971A1 (en) | Composition for stabilizing biological materials | |
| Record et al. | The survival of Escherichia coli on drying and rehydration | |
| WO2006029467A1 (en) | Rapid freeze drying process | |
| CN1286725A (en) | Vitrification preservation method for sensitive biological samples | |
| Mazur | Mechanisms of injury in frozen and frozen-dried cells | |
| Imamura et al. | Water sorption and glass transition of amorphous sugars containing BSA | |
| MXPA00005123A (en) | Preservation of sensitive biological samples by vitrification | |
| Rowe | A review of freeze-drying technology | |
| Crowe et al. | Dry biology systems | |
| May et al. | Cryopreservation and molecular distillation drying of mammalian cells | |
| Spieles et al. | Glass transition curves of aqueous solutions for the freeze-drying of biomaterials |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK TJ TM TR TT UA UG UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT |
|
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK TJ TM TR TT UA UG UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| ENP | Entry into the national phase |
Ref document number: 2256333 Country of ref document: CA Ref country code: CA Ref document number: 2256333 Kind code of ref document: A Format of ref document f/p: F |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1997927769 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWP | Wipo information: published in national office |
Ref document number: 1997927769 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1997927769 Country of ref document: EP |